The Emerging Science of Cannabis and CBD

The Emerging Science of Cannabis and CBD

Anecdotal evidence abounds for CBD and hemp supplements, but what does the actual scientific literature say? What potential benefits are biologically plausible, why and how? What kind of doses are needed to elicit a health benefit? And what does the data really say about potential adverse events? In this webinar, our panel of experts will discuss the endocannabinoid system, and what peer-reviewed data does (and doesn’t) support for hemp-derived cannabinoids, including CBD, and terpenes.


Andrea Holmes, Ph.D. Andrea Holmes, Ph.D. Chief Growth Officer
Precision Plant Molecules

Douglas MacKay, N.D. Douglas MacKay, N.D. Senior Vice President of Scientific and Regulatory Affairs
CV Sciences

Igor Koturbash, MD, PhD Igor Koturbash, MD, PhD Founder and Co-Director of the Center for Dietary Supplements Research
University of Arkansas for Medical Sciences

Stephen Daniells, PhD Stephen Daniells, PhD Editor in Chief of the Americas
William Reed Business Media